Editorials

• PCSK9 Inhibitors: From Innovation to Sustainable Clinical Application

  Iñaki Lekuona

  Rev Esp Cardiol. 2018;71:996-8

• Heart Disease and Vehicle Driving: Novelties in European and Spanish Law

  Alberto García Lledó, Elena Valdés Rodríguez, Marta Ozcoidi Val

  Rev Esp Cardiol. 2018;71:892-4

• The Subcutaneous ICD. Ready to Conquer Everyone's Heart?

  Lucas V.A. Boersma

  Rev Esp Cardiol. 2018;71:886-7

• Childhood Obesity: An Unresolved Issue

  Javier Aranceta-Bartrina, Carmen Pérez-Rodrigo

  Rev Esp Cardiol. 2018;71:888-91

• Bifurcation Lesions Causing an STEMI. Are They a Different Animal?

  Manuel Pan, Soledad Ojeda

  Rev Esp Cardiol. 2018;71:779-81

• Current Situation of the Treatment of Arrhythmias in Children in Spain. Finding a Place of its Own

  Ferran Rosés-Noguer, Ángel Moya-Mitjans

  Rev Esp Cardiol. 2018;71:775-8

• Antithrombotic Therapy in Acute Coronary Syndrome: Striking a Happy Medium

  Francesco Costa, Salvatore Brugaletta

  Rev Esp Cardiol. 2018;71:782-6

• Comments on the 2018 ESC Guidelines for the Diagnosis and Management of Syncope

  SEC Working Group for the 2018 ESC Guidelines for Syncope, Expert Reviewers for the 2018 ESC Guidelines for Syncope, and the SEC Guidelines Committee, Working Group of the SEC for the 2018 ESC Guidelines for the Diagnosis and Management of Syncope:Expert Reviewers for the ESC Guidelines for the Diagnosis and Management of SyncopeSEC Guidelines Committee

  Rev Esp Cardiol. 2018;71:787-93

• Evidence and Indications for Percutaneous Closure of the Left Atrial Appendage

  Vincent F.M. Segers, Hein Heidbuchel

  Rev Esp Cardiol. 2018;71:700-2

• Vaccination in Heart Failure: An Approach to Improve Outcomes

  Nikolaos P.E. Kadoglou, John Parissis, Petar Seferovic, Gerasimos Filippatos

  Rev Esp Cardiol. 2018;71:697-9

• Do Male Hearts Break Differently?

  Birke Schneider, Udo Sechtem

  Rev Esp Cardiol. 2018;71:695-6

• New Targets in Arterial Hypertension, Are They Justified?

  Vivencio Barrios, Carlos Escobar

  Rev Esp Cardiol. 2018;71:608-11

• Reversibility of Alcohol Dilated Cardiomyopathy

  Joaquim Fernández Solà

  Rev Esp Cardiol. 2018;71:603-5

• Predicting Recurrent Restenosis After Drug-eluting Balloon: A First Step Toward Personalized Treatment

  Raffaele Piccolo, Philippe Kolh

  Rev Esp Cardiol. 2018;71:606-7

• The Ideal Lipid Report: A Need for Consensus

  Juan Pedro-Botet, Luis Rodríguez-Padial, Carlos Brotons, Margarita Esteban-Salán, Aurora García-Lerín, Xavier Pintó, Iñaki Lekuona, Jordi Ordóñez-Llanos

  Rev Esp Cardiol. 2018;71:512-4

• Health Professionals, Organizations and the Health System: Making What Is Socially Advisable Individually Attractive

  Carlos Campillo-Artero, Vicente Ortún

  Rev Esp Cardiol. 2018;71:520-3

• The Clinical Decision: A Clue to Health Services Outcomes Everywhere

  Carlos Campillo-Artero, Vicente Ortún

  Rev Esp Cardiol. 2018;71:515-9

• “Everything Should be Made as Simple as Possible but Not Simpler”

  Thierry Lefevre, Yves Louvard

  Rev Esp Cardiol. 2018;71:418-9

• Should We Up the Intensity of Statin Therapy After Placing a Drug-eluting Stent?

  Kinjan H. Parikh, Ajay J. Kirtane

  Rev Esp Cardiol. 2018;71:416-7

• Angiogenesis and Microvascular Obstruction: Still a Research Topic or a New Therapeutic Target?

  Francesco Fracassi, Giampaolo Niccoli

  Rev Esp Cardiol. 2018;71:420-2